High affinity human antibodies to human protease-activated receptor-2

Details for Australian Patent Application No. 2010292342 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Macdonald, Lynn; Murphy, Andrew J.; Papadopulos, Nicholas J.; Morra, Marc R.; Salzler, Robert R.; Laccroix-Fralish, Michael L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010292342

PCT Pub. Number WO2011/031695

Priority 61/317,839 26.03.10 US; 61/240,783 09.09.09 US; 61/242,821 16.09.09 US

Filing date 8 September 2010

Wipo publication date 17 March 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/031695 Priority application(s): WO2011/031695

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010292346-Systems and methods for polyphase alternating current transformer inrush current limiting

2010292341-Reconstitution and applicator system for wound sealant product